ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 628906 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 628906; 2) Community: the network communities that were significantly associated with the response to NSC 628906; 3) Molecule: the relationships between components within communities and NSC 628906; 4) MDR: the compounds that were significantly associated with the NSC 628906.

NSC Compound Enrichment Correlation
NSC 610458 Camptothecin Derivative 0.0103070729572494 0.2947185
NSC 619859 1H-3-Benzazepin-2-one, 2,3,4,5-tetrahydro-7,8-dimethoxy- 3-[(2,3-dimethoxyphenyl)methyl]-1-methylthio- 0.0103070729572494 0.16324847
NSC 627168 2-[(3-N',N'-Dimethylamino)propyl]-9-methoxy-5-nitro-[6H]- pyrazolo[3,4,5-kl]acridine, free base 0.0103070729572494 0.13665188
NSC 639174 Camptothecin Derivative 0.0103070729572494 0.29241059
NSC 658247 Pyridine-3,5-dicarboxylic acid, 1,4-dihydro-2,6-dimethyl-, bis[2-(2-hydroxybenzoyl)hydrazide] 0.0103070729572494 0.12079807
NSC 681639 Camptothecin Derivative 0.0103070729572494 0.27766806
NSC 693773 Null 0.0103070729572494 0.27234031
NSC 706743 5H-[1,3]Dioxolo[5,6]indeno[1,2-c]isoquinoline- 5,12(6H)-dione,6-[3-[(2-hydroxyethyl)amino]propyl]-2,3-dimethoxy- (9CI) 0.0103070729572494 0.26040643
NSC 93739 Aizen Magenta 0.0103070729572494 -0.11969303
NSC 689857 Benzoic acid, 4-[[(2,5-dihydroxyphenyl)methyl]amino]-, 1-adamantanemethyl ester 0.0103070729572495 0.30275022
Total:53  Current:12    [First] [Prev] [Next] [Last]